Related Experiment Video
Updated: Jan 11, 2026

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
Published on: June 18, 2020
Diagnosis of Portal Hypertension
Søren Møller1,2, Karen V Danielsen1,3, Lise Hobolth3
1Department of Clinical Physiology and Nuclear Medicine, Center for Functional and Diagnostic Imaging and Research, Copenhagen University Hospital Hvidovre, DK-2650 Hvidovre, Denmark.
Insights
Chronic liver disease causes portal hypertension, a condition best assessed by hepatic venous pressure gradient (HVPG) measurement. HVPG guides diagnosis, prognosis, and treatment, crucial for managing this global health issue.
Area of Science:
- Hepatology
- Cardiovascular Medicine
- Gastroenterology
Background:
- Chronic liver disease (CLD) presents a significant global health challenge.
- Portal hypertension (PH) and its complications arise from complex pathophysiological mechanisms within the liver.
- Effective management of CLD and PH necessitates a thorough understanding of these underlying processes.
Purpose of the Study:
- To review the comprehensive management of patients suffering from portal hypertension (PH).
- To highlight the critical indications for measuring the hepatic venous pressure gradient (HVPG) in PH patients.
- To emphasize the role of HVPG in diagnosis, prognosis, and guiding therapy for PH.
Main Methods:
- This review synthesizes current knowledge on PH management.
- It focuses on the diagnostic and prognostic utility of the hepatic venous pressure gradient (HVPG).
- The role of non-invasive tests is discussed in comparison to HVPG.
Main Results:
- The hepatic venous pressure gradient (HVPG) is the gold standard for assessing PH severity and guiding treatment.
- HVPG measurement provides essential prognostic information and helps determine the need for pharmacological interventions.
- Reductions in HVPG correlate with improved patient outcomes.
- Non-invasive methods are valuable but do not fully replace HVPG for precise assessment.
Conclusions:
- Accurate assessment of portal hypertension through HVPG measurement is vital for effective patient management.
- HVPG guides therapeutic decisions, including the initiation and monitoring of treatments like beta-blockers.
- Understanding HVPG's role is crucial for improving outcomes in patients with chronic liver disease and PH.
Abstract:
Chronic liver disease (CLD) imposes a major global health burden, with portal hypertension (PH) and its complications driven by complex pathophysiological mechanisms. Understanding these processes is essential for effective therapy. The hepatic venous pressure gradient (HVPG) is the gold standard for assessing portal hypertension, providing key diagnostic, prognostic, and therapeutic guidance-particularly in distinguishing its type and monitoring response to treatments such as non-selective beta-blockers. While non-invasive tests like elastography and serum biomarkers are valuable for screening and follow-up, they cannot fully replace HVPG when precise measurement is needed. HVPG contains not only prognostic information but also helps to decide if pharmacological therapy is indicated and to monitor therapeutic effects with reductions correlating with improved outcomes. In this review, we highlight the comprehensive management of patients with PH and the indications for measurement of HVPG.
Related Concept Videos
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Esophageal Varices-I: Introduction
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Endoscopic Procedures V: ERCP
Patient...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

